Biswajit Das

发表

Analytical Validation and Application of a Targeted Next-Generation Sequencing Mutation-Detection Assay for Use in Treatment Assignment in the NCI-MPACT Trial.

David J. Sims, R. Simon, L. Rubinstein, 2016, The Journal of molecular diagnostics : JMD.

Robustness of Next Generation Sequencing on Older Formalin-Fixed Paraffin-Embedded Tissue

Brenda Y. Hernandez, Charles F. Lynch, Leah E. Mechanic, 2015, PloS one.

RefCNV: Identification of Gene-Based Copy Number Variants Using Whole Exome Sequencing

E. Polley, L. Chang, C. Lih, 2016, Cancer informatics.

Circulating tumor DNA sequencing provides comprehensive mutation profiling for pediatric central nervous system tumors

P. M. Williams, S. Mueller, R. Packer, 2022, npj Precision Oncology.

Certified DNA Reference Materials to Compare HER2 Gene Amplification Measurements Using Next-Generation Sequencing Methods.

David J. Sims, S. Lund, J. Almeida, 2016, The Journal of molecular diagnostics : JMD.

Cross-Site Concordance Evaluation of Tumor DNA and RNA Sequencing Platforms for the CIMAC-CIDC Network

P. A. Futreal, Daoud M. Meerzaman, S. Gabriel, 2020, Clinical Cancer Research.

TPM, FPKM, or Normalized Counts? A Comparative Study of Quantification Measures for the Analysis of RNA-seq Data from the NCI Patient-Derived Models Repository

Yvonne A. Evrard, L. McShane, J. Doroshow, 2021, Journal of Translational Medicine.

Development and interlaboratory evaluation of a NIST Reference Material RM 8366 for EGFR and MET gene copy number measurements

Steven P. Lund, S. Lund, J. Almeida, 2019, Clinical chemistry and laboratory medicine.

Safety, Antitumor Activity, and Biomarker Analysis in a Phase I Trial of the Once-daily Wee1 Inhibitor Adavosertib (AZD1775) in Patients with Advanced Solid Tumors

L. Rubinstein, J. Doroshow, A. Chen, 2021, Clinical Cancer Research.

Molecular Profiling-Based Assignment of Cancer Therapy (NCI-MPACT): A Randomized Multicenter Phase II Trial

David J. Sims, J. Foster, R. Simon, 2021, JCO precision oncology.

Plasmid-Based Materials as Multiplex Quality Controls and Calibrators for Clinical Next-Generation Sequencing Assays.

Robin D Harrington, Chih-Jian Lih, Courtney H Bouk, 2016, The Journal of molecular diagnostics : JMD.

Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II Study.

H. Kohrt, R. Pierce, H. Maecker, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Durable Responses with Pembrolizumab in Relapsed/Refractory Mycosis Fungoides and Sézary Syndrome: Final Results from a Phase 2 Multicenter Study

H. Kohrt, H. Maecker, J. Yearley, 2018, Blood.

TPM, FPKM, or Normalized Counts? A Comparative Study of Quantification Measures for the Analysis of RNA-seq Data from the NCI Patient-Derived Models Repository

Yvonne A. Evrard, L. McShane, J. Doroshow, 2021, Journal of Translational Medicine.

Differential expression of miRNAs between Young-Onset and Late-Onset Indian colorectal carcinoma patients

Biswajit Das, Sudarshana Basu, N. Banerjee, 2023, bioRxiv.

Challenges and Future Directions in the Management of Tumor Mutational Burden-High (TMB-H) Advanced Solid Malignancies

Biswajit Das, Jibran Ahmed, Sarah Shin, 2023, Cancers.